.Amgen has actually shared (PDF) the very first stage 3 records on its $400 thousand chronic eczema ...
.Biogen and UCB's gamble on improving in to phase 3 on the back of a failed study looks to have actu...
.Italian biotech Aptadir Therapeutics has launched along with the guarantee that its pipe of preclin...
.Wave Life Sciences has fulfilled its own objective in a Duchenne muscle dystrophy (DMD) research, i...
.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, takin...
.Achilles Therapies has actually wrecked its own method. The English biotech is actually stopping wo...
.Aligos Therapeutics is heralding a midstage succeed in metabolic-dysfunction associated steatohepat...
.Basilea Pharmaceutica's job establishing brand-new antifungals has received a significant boost fro...
.Having actually scooped up the U.S. legal rights to Capricor Therapies' late-stage Duchenne muscle ...
.After pushing back the decision meeting for Applied Therapies' metabolic ailment medication govores...